Avista Healthcare Public Acquisition Corp. Announces Merger Agreement
by Kristi Marvin on 2018-08-20 at 12:38pm

(The post below is an excerpt from the weekly subscriber email sent out every Monday morning before the market open.)


Avista Disappoints…

Question: If a SPAC announces their acquisition on a summer Friday, in the back half of August, after 5:00PM and without a follow-up conference call, do you think the SPAC team is eager to talk to investors? The obvious answer is no, but that’s just what Avista Public Healthcare Acquisition Corp. did this past Friday afternoon, and with good reason.

Avista announced they had entered into a merger agreement with Organogenesis,  a regenerative medicine company, for an anticipated initial enterprise value of approximately $673 million.  However, how Avista structured this transaction is not going to make investors happy.

Before we get into the details, you should now that investors will not get hurt in this transaction.  You will be able to redeem your shares.  However, investors aren’t investing in SPACs to “not get hurt”. You can invest in a Money Market or T-Bills for that.  SPAC investors are investing for a great return and unfortunately, the Avista deal is not going to provide that.

You can read the fine print on the announced deal here, but what you need to know is that Avista will be doing a PIPE with “affiliates of Avista,”  for $92 million ($46 at merger agreement and $46 million at closing) at effectively, $7.04.  Yes, you read that right. Due to that price, Avista expects full redemption of the Trust (obviously), but the real kicker is that the warrant strike is not being adjusted. So while at a $10.00 share price the warrants were $1.50 out-of-the-money ($11.50 strike), the warrants will now be ~$4.50 out-of-the-money (same strike of $11.50), making them far, far less valuable.

After reading the details, two things immediately come to mind:

One, if the Avista team ever wants to do another SPAC, they’re going to have to pay a LOT more for it. Any subsequent SPACs they attempt are probably going to require over-funding the trust or additional terms so that investors feel comfortable.   It’s a case of, “Fool me once…”

The second thing that comes to mind is a term that was included in the Crescent Funding SPAC.  If you remember, Crescent Funding Inc., filed for IPO back in January of 2018, but eventually withdrew their registration statement (most likely due to market conditions). However, the filing, which you can still find on SEC.gov, included a term for the warrants that stated Crescent would adjust the strike of the warrants in the event they:

“…issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.”

It’s a great term and the take away here is, if we continue to see more business combinations structured like Avista, you can be sure investors will demand it.

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-28 at 7:47am

At the SPAC of Dawn Fed Chair Jerome Powell has given new hints that the administration would be showing greater levels of comfort with inflation if a cut could help improve unemployment numbers. Those numbers could get an update today at 8:30 am ET to bring new jobless claims as well as final prices for...

by Nicholas Alan Clayton on 2024-03-27 at 1:31pm

News and Rumors CNBC: Former WeWork (OTC Pink:WEWKQ) founder Adam Neumann has offered to buy back control of the company for $500 million but has yet to secure the necessary financing. WeWork went public with BowX in October 2021. PR: Satellite telecom firm Spire Global (NYSE:SPIR) has signed an agreement to build and launch two...

by Nicholas Alan Clayton on 2024-03-27 at 11:38am

Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...

by Nicholas Alan Clayton on 2024-03-27 at 7:33am

At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....

by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved